Ensign Peak Advisors’s Vor Biopharma VOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-329,378
| Closed | -$366K | – | 1729 |
|
|
2024
Q4 | $366K | Hold |
329,378
| – | – | ﹤0.01% | 1658 |
|
|
2024
Q3 | $231K | Sell |
329,378
-16,709
| -5% | -$11.7K | ﹤0.01% | 1685 |
|
|
2024
Q2 | $346K | Hold |
346,087
| – | – | ﹤0.01% | 1671 |
|
|
2024
Q1 | $820K | Hold |
346,087
| – | – | ﹤0.01% | 1439 |
|
|
2023
Q4 | $779K | Hold |
346,087
| – | – | ﹤0.01% | 1517 |
|
|
2023
Q3 | $734K | Hold |
346,087
| – | – | ﹤0.01% | 1421 |
|
|
2023
Q2 | $1.07M | Hold |
346,087
| – | – | ﹤0.01% | 1203 |
|
|
2023
Q1 | $1.86M | Buy |
346,087
+46,587
| +16% | +$251K | ﹤0.01% | 876 |
|
|
2022
Q4 | $1.99M | Buy |
299,500
+90,000
| +43% | +$599K | ﹤0.01% | 817 |
|
|
2022
Q3 | $834K | Buy |
+209,500
| New | +$834K | ﹤0.01% | 1170 |
|
|
2022
Q2 | – | Sell |
-40,426
| Closed | -$244K | – | 2205 |
|
|
2022
Q1 | $244K | Hold |
40,426
| – | – | ﹤0.01% | 1820 |
|
|
2021
Q4 | $470K | Buy |
+40,426
| New | +$470K | ﹤0.01% | 1652 |
|